United States · FDA National Drug Code directory
EXEMESTANE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-316_60b57295-ef43-4721-94c4-58a4c5689420
- Product NDC
- 69097-316
- Form
- TABLET
- Composition / generic term
- exemestane
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180427
- Source listing expiry
- 20261231
Source-listed ingredients
- EXEMESTANE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (69097-316-02) · 69097-316-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →